Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001190725-19-000018
Filing Date
2019-05-20
Accepted
2019-05-20 16:43:12
Documents
1
Period of Report
2019-05-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3723
  Complete submission text file 0001190725-19-000018.txt   5245
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ACLARA BIOSCIENCES INC 1288 PEAR AVE MOUNTAIN VIEW CA 94043
Business Address
LIMBER JOSEPH M (Reporting) CIK: 0001216023 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14710 | Film No.: 19839363